Sign Up to like & get
recommendations!
1
Published in 2023 at "Molecules"
DOI: 10.3390/molecules28093861
Abstract: Elagolix sodium salt is the first marketed orally active non-peptide gonadotropin-releasing hormone receptor antagonist (GnRHR-ant) for the management of hormone dependent diseases, such as endometriosis and uterine fibroids. Despite its presence on the market since…
read more here.
Keywords:
elagolix sodium;
synthetic intermediates;
salt synthetic;
sodium salt ... See more keywords